Salt Lake City--Lineagen, Inc., a molecular diagnostics company focused on disorders of childhood development.

PositionAround Utah

Salt Lake City -- LINEAGEN, INC., a molecular diagnostics company focused on disorders of childhood development, closed the second and final tranche of its $15.8 million Series C round...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT